mRNA-Engineered Mesenchymal Stromal Cells Expressing CXCR2 Enhances Cell Migration and Improves Recovery in Inflammatory Bowel Disease

A new strategy to modify MSCs to express specific chemokine receptors using mRNA engineering was developed to evaluate the homing ability of MSCs and its therapeutic effects for inflammatory bowel disease.